
Our mission is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer.
The Susan G Komen Breast Cancer Fdn Group’s recent giving is defined by a single large 2023 grant of $1,078,283 to See Attached Statement in Dallas. That award fits a broader breast-cancer grantmaking profile centered on research, metastatic disease, precision medicine, clinical trials, and patient support. The foundation’s public mission is to save lives by meeting critical community needs and investing in breakthrough research to prevent and cure breast cancer. Across its active grant programs, the foundation uses several research channels rather than a single pooled program. It funds scientific research grants, career-stage support for early investigators, and collaborative initiatives focused on metastatic breast cancer and inflammatory breast cancer. It also maintains awards and scholarships for investigators and trainees, showing an interest in building research capacity alongside project funding. The research emphasis is tightly linked to clinical and patient-facing priorities. Its listed focus areas include screening and early detection, patient navigation and psychosocial support, health equity and disparities, and access to clinical trials for diverse and underrepresented populations. That combination places the foundation at the intersection of scientific research and practical support for people living with breast cancer and their caregivers.
Breast cancer research is the center of the foundation’s grantmaking. The active program list includes Scientific Research Grants, Career Catalyst Research Grants, Career Transition Awards, and an Inflammatory Breast Cancer Initiative, all aimed at research in breast cancer, metastatic disease, aggressive disease, personalized medicine, and disparities. Career development is another clear thread. The Susan G Komen Career Catalyst Research Grants support early-stage faculty with protected research time and career development, while Career Transition Awards are designed to help postdoctoral fellows and clinical fellows move into independent research careers. The foundation also backs collaborative and applied work. Its Metastatic Breast Cancer Collaborative Research Initiative supports collaborative research on metastatic breast cancer, and the Center for Applied Research supports projects intended to translate findings into improved breast health outcomes through applied research, health services research, implementation science, and health equity.
$1.1M
$112K
$1.5M
$10.2M
Most grants fall between $1.1M and $1.1M, with a median of $1.1M.
25th Percentile
$1.1M
Median
$1.1M
75th Percentile
$1.1M
About 100% of grants go to recipients in TX.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The typical grant size is fixed in the file: p25, median, and p75 are all $1,078,283. That lines up with the latest reported grant, which was also $1,078,283 in 2023. The foundation’s public charity status and program structure point to institutional grantmaking rather than individual aid, and it does not make program-related investments. The active program list shows a mix of invitation-only research programs and one awards-and-scholarships track that accepts unsolicited applications. Several programs are explicitly restricted to the United States, while others also include international geography. The recent grant record shows a one-grant snapshot in the file, so recurring recipients cannot be inferred from the provided data.
Giving is tightly concentrated in Texas: 100% of the grants in the file go to recipients in the HQ state, and TX is also the top state by grant count. The recent grant list names Dallas as the recipient city for the latest award. The recipient-country distribution is entirely U.S.-based, with 1 grant and 100.0% in the United States. Although some active programs allow U.S. and international geography, the grant record provided shows local Texas distribution.
The listed focus areas are breast cancer research, metastatic breast cancer, precision medicine, clinical trials, patient support services, health equity and disparities, screening and early detection, patient navigation and psychosocial support, and access to clinical trials for diverse and underrepresented populations.
Its active programs include Scientific Research Grants, Career Catalyst Research Grants, Career Transition Awards, an Inflammatory Breast Cancer Initiative, a Metastatic Breast Cancer Collaborative Research Initiative, a Center for Applied Research, and Awards & Scholarships for investigators and trainees.
Most listed programs do not. The Awards & Scholarships (Fellowships and Career Development Awards) track is marked as accepting unsolicited applications, while the research grant programs and initiatives shown are marked False for unsolicited applications.
The grant record is fully concentrated in Texas, with 100% of grants to recipients in the HQ state. The latest grant went to See Attached Statement in Dallas, and the recipient-country distribution is entirely U.S.-based.
The file shows a single repeated grant-size value: p25, median, and p75 are all $1,078,283. The latest reported grant is also $1,078,283, so the typical size in this dataset is a single-point figure rather than a range.
2023
Source: IRS Form 990-PF, fiscal year 2023.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| SEE ATTACHED STATEMENT | Dallas, TX | $1,078,283 | 2023 | VARIOUS |
SEE ATTACHED STATEMENT
$1,078,283VARIOUS